ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence.

L-アルギニンとL-シトルリンの併用またはL-シトルリン単独投与は内皮細胞の老化を遅延させた (機械翻訳の邦題)

PloS one2018Tsuboi T, Maeda M, Hayashi T
研究デザインその他の原著論文
対象ヒト・動物 併記

記録の確認項目

研究デザイン
その他の原著論文
対象
ヒト・動物 併記
出版年
2018
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/03
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

本研究は、L-アルギニン(L-Arg)とL-シトルリン(L-Cit)の補充が内皮細胞の老化と機能に及ぼす影響を検討した。高グルコース(HG)刺激したヒト臍帯静脈内皮細胞(HUVEC)にL-Arg、L-Cit、または両者併用(LALC)を添加し、老化関連β-ガラクトシダーゼ(SA-β-gal)活性、p16INK4a発現、DNA損傷、テロメラーゼ活性、NO産生、ROS産生、アルギナーゼ2発現を評価した。また、高コレステロール食のZDFMラットに4週間投与し、大動脈内皮の老化を評価した。結果、L-CitとLALCはHG誘発性の内皮老化を遅延させ、テロメラーゼ活性を正常化し、NO産生を増加させた。一方、L-Arg単独では効果がなかった。L-CitはROS産生とアルギナーゼ2発現を抑制し、eNOSリン酸化を増加させた。ラットでもL-CitとLALCはSA-β-gal活性を低下させ、LALCは血漿NOを増加させた。結論として、L-Cit補充はL-Argより効果的にNOを回復させ、内皮老化を遅延させる。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

L-citrulline and L-arginine supplementation has been shown to have several beneficial effects on the cardiovascular system. Nitric oxide (NO) protects against the progression of atherosclerosis and is synthesized by nitric oxide synthase (NOS), which converts L-arginine (L-Arg) into L-citrulline (L-Cit). Our previous study revealed that chronic administration of a combination of L-Cit and L- Arg has a better therapeutic effect on high cholesterol-induced atherosclerosis in rabbits. We investigated how L-Arg and L-Cit affect endothelial function, aging and atherosclerosis. Following a 3-day stimulation of human umbilical venous endothelial cells (HUVECs) with high glucose (HG: 22 mM) and L-Arg (300 μM), L-Cit (300 μM) or L-Arg plus L-Cit (LALC: each 150 μM) supplementation, endothelial senescence and function were evaluated. These amino acids were also administered to dyslipidemic type 2 diabetic (ZDFM) rats fed a high cholesterol diet. They were fed L-Arg or L-Cit or LALC for four weeks. Aortic senescence was investigated by measuring senescence-associated ß-galactosidase (SA-ß-gal), telomerase activity, DNA damage and p16INK4a protein expression. Only L-Cit and LALC supplementation retarded the HG-induced endothelial senescence, as evaluated by SA-ß-gal activity, a widely used marker of cellular senescence, p16INK4a expression, a senescence-related protein, and DNA damage. Under HG conditions, L-Cit and LCLA restored telomerase activity to levels observed under normal glucose (NG) conditions. Under HG conditions, L-Cit decreased ROS production, as measured by CM-H2DCFDA and the expression of p67phox, a major component of NADPH oxidase. Under HG conditions, L-Cit and LALC increased NO production, as measured by DAF-2AM. Endothelial NO synthase (eNOS) and phosphorylated eNOS were decreased under HG conditions and L-Cit and LALC significantly increased these levels. Arginase 2 protein expression increased under the HG conditions, and L-Cit and LALC significantly attenuated this effect. In ZDFM rats, SA-ß-gal activity was detected on the aortic endothelial surface; however, L-Cit and LALC reduced these levels. L-Cit and LALC both decreased the proportion of senescent cells. Furthermore, treatment with LALC for 4 weeks increased plasma NO production. Therefore conclusively, L-citrulline supplementation rescued NO levels better than L-arginine supplementation by inhibiting ROS production and arginase 2 protein expression. Consequently, L-Cit and LCLA supplementation retaeded HG-induced endothelial senescence.

MeSH

AnimalsArginineCellular SenescenceCitrullineEndothelium, VascularHuman Umbilical Vein Endothelial CellsHumansRatsRats, Zucker

DOI 10.1371/journal.pone.0192252

PMID 29415069

原文・出典を見る →